The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research
Open accessAbstract
Introduction: Performance status (PS) is a standard functional classification in oncology research and practice. However, despite its widespread use, little is known about the prevalence of poor PS in lung cancer patients, in relation to other cancers, based on the assessments of health care providers and patients. Methods: Data from two quality of life studies were pooled for analysis. Analyses were performed on the subset of patients with lung cancer (n = 503) from the entire population of cancer patients (n = 2885). The prevalence of poor PS (defined as PS = 2–4 on a 0–4 scale) was determined for lung cancer patients. Results: Prevalence of poor PS among lung cancer patients was 34% when estimated by providers and 48% when estimated by patients themselves. Agreement between providers and patients was only fair (weighted [kappa] = 0.41). For both advanced and early stage disease, lung cancer patients were at the highest risk for poor PS compared with other common cancers. Conclusions: The prevalence of poor PS is quite high in lung cancer patients. Providers tend to underestimate poor PS. Specific clinical trials and treatment guidelines for this patient population are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Self-citation
Cited by
Kawaguchi, T., Takada, M., Kubo, A., Matsumura, A., Fukai, S., Tamura, A., Saito, R., Maruyama, Y., Kawahara, M., & Ignatius Ou, S.-H. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d2dcd9 · Cited by 354
Prevalence and risk factors of cancer-related fatigue: A systematic review and meta-analysis
Ma, Y., He, B., Jiang, M., Yang, Y., Wang, C., Huang, C., & Han, L. (2020) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2020.103707 · Cited by 326
Licker, M., Karenovics, W., Diaper, J., Frésard, I., Triponez, F., Ellenberger, C., Schorer, R., Kayser, B., & Bridevaux, P.-O. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.09.125 · Cited by 255
Metadata
- Authors
- Lilenbaum, R. C., Cashy, J., Hensing, T. A., Young, S., & Cella, D.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 3
- Issue
- 2
- Pages
- 125-129
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W1981049999
- Cited by
- 221
- References
- 2
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research. https://app.cochat.ai/papers/10.1097/jto.0b013e3181622c17
- The paper
- Lilenbaum, R. C., Cashy, J., Hensing, T. A., Young, S., & Cella, D. (2008). Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research. Journal of Thoracic Oncology. https://doi.org/10.1097/jto.0b013e3181622c17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.